Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.07.019 ◽

2021 ◽

Author(s):

Olga M Pijpers ◽

Kees Hendricksen ◽

Hugh Mostafid ◽

Florus C de Jong ◽

Marloes Rosier ◽

...

Keyword(s):

Bladder Cancer ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Term Efficacy ◽

Muscle Invasive

Download Full-text

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Case Medical Research ◽

10.31525/ct1-nct04164082 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Cancer Drug ◽

Chemotherapy Treatment ◽

Muscle Invasive Bladder Cancer ◽

Anti Cancer ◽

Muscle Invasive

Download Full-text

Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer

Acta Oncologica ◽

10.1080/0284186x.2021.1915498 ◽

2021 ◽

pp. 1-9

Author(s):

Emmanuelle Fabiano ◽

Catherine Durdux ◽

Bertrand Dufour ◽

Arnaud Mejean ◽

Nicolas Thiounn ◽

...

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Long Term Outcomes ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure

Arab Journal of Urology ◽

10.1080/2090598x.2021.1874627 ◽

2021 ◽

pp. 1-6

Author(s):

Francesco Chiancone ◽

Marco Fabiano ◽

Maurizio Carrino ◽

Maurizio Fedelini ◽

Clemente Meccariello ◽

...

Keyword(s):

Bladder Cancer ◽

Inflammatory Markers ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Long-Term Outcomes and Costs Among BCG-treated High-Risk Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.10.041 ◽

2020 ◽

Vol 38 (12) ◽

pp. 902

Author(s):

SB Williams ◽

LE Howard ◽

ML Foster ◽

Z Klaassen ◽

H Li ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Equal Access ◽

Invasive Bladder Cancer ◽

Long Term Outcomes ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Long-term versus short-term introvesical chemotherapy in patients with non-muscle-invasive bladder cancer: A systematic review and meta-analysis of the published results of randomized clinical trials

Journal of Huazhong University of Science and Technology [Medical Sciences] ◽

10.1007/s11596-014-1340-y ◽

2014 ◽

Vol 34 (5) ◽

pp. 706-715

Author(s):

Teng Li ◽

Yi Xing ◽

Shu-cheng Liu ◽

Xiao-min Han ◽

Wen-cheng Li ◽

...

Keyword(s):

Systematic Review ◽

Bladder Cancer ◽

Clinical Trials ◽

Randomized Clinical Trials ◽

Meta Analysis ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Perioperative Intravesical Chemotherapy for Patients WithNon–Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use

Urology ◽

10.1016/j.urology.2018.10.016 ◽

2019 ◽

Vol 124 ◽

pp. 107-112

Author(s):

Devon K. Check ◽

David S. Aaronson ◽

Matthew E. Nielsen ◽

Valerie S. Lee ◽

Isaac J. Ergas ◽

...

Keyword(s):

Bladder Cancer ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Sources Of Variation ◽

Muscle Invasive

Download Full-text

Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

European Urology ◽

10.1016/j.eururo.2011.07.032 ◽

2011 ◽

Vol 60 (4) ◽

pp. 870-871

Author(s):

Damien Pouessel ◽

Stéphane Culine ◽

Pierre Mongiat-Artus

Keyword(s):

Bladder Cancer ◽

Phase Iii ◽

Long Term Results ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Phase Iii Trial ◽

Muscle Invasive

Download Full-text

Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?

BJU International ◽

10.1111/j.1464-410x.2009.09152.x ◽

2010 ◽

Vol 105 ◽

pp. 14-17 ◽

Author(s):

Benjamin E. Ayres ◽

Jeremy P. Crew

Keyword(s):

Bladder Cancer ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer

International Journal of Hyperthermia ◽

10.3109/02656736.2014.900194 ◽

2014 ◽

Vol 30 (3) ◽

pp. 166-170 ◽

Author(s):

Alejandro Sousa ◽

Brant A. Inman ◽

Idelfonso Piñeiro ◽

Victor Monserrat ◽

Alberto Pérez ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Long-term outcomes of bladder preservation in muscle-invasive bladder cancer patients

Annals of Oncology ◽

10.1093/annonc/mdz425.010 ◽

2019 ◽

Vol 30 ◽

pp. ix74

Author(s):

A.D. Satiti ◽

H. Mistry ◽

Y.P. Song ◽

A. Choudhury

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Long Term Outcomes ◽

Muscle Invasive Bladder Cancer ◽

Bladder Preservation ◽

Muscle Invasive

Download Full-text